Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 oct. 2019 12h58 HE | Source: NX Development Corp.

Lexington-Based NX Development Corp (NXDC) Announces Baptist Health Lexington is First Hospital in Kentucky to Use Breakthrough Imaging Agent for Brain Tumor Visualization

Lexington, KY, Oct. 03, 2019 (GLOBE NEWSWIRE) -- NX Development Corp (NXDC), a life sciences company based in Lexington, KY, today announced Baptist Health Lexington is the first hospital in state...
13 févr. 2019 09h15 HE | Source: Oncotelic Inc

Oncotelic Reports that It's Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma

Phase 2 Clinical Data Presented at 11th AACR-JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision MedicineOT-101 exhibited promising single agent clinical activity as second...
03 oct. 2018 14h50 HE | Source: NX Development Corp.

NX Development Corp. (NXDC) Launches FDA-Approved Gleolan™ (aminolevulinic acid HCl) for Enhanced Visualization of High-Grade Gliomas (including Glioblastomas)

Lexington, KY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- NX Development Corp. (NXDC), a life sciences company, today announced the U.S. commercial launch of its flagship product Gleolan™ (aminolevulinic...
22 déc. 2017 09h03 HE | Source: The Jackson Laboratory

Profiling Brain Cancers for More Targeted Treatments

Farmington, Conn., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Roel Verhaak, Ph.D., is not beholden to the status quo. After all, his field, computational biology, didn’t exist, at least not formally, when he...
03 avr. 2014 08h10 HE | Source: ClearPoint Neuro, Inc.

MRI Interventions to Exhibit its ClearPoint Neuro Intervention System at AANS 2014 Annual Meeting

IRVINE, Calif., April 3, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Intervention System will be on exhibit at the 2014 Annual Meeting...
03 déc. 2013 08h00 HE | Source: ClearPoint Neuro, Inc.

Importance of Real-Time MRI Guidance in Delivery of Toca 511 Gene Therapy Directly to High Grade Glioma Presented at Annual Society for Neuro-Oncology Scientific Meeting

IRVINE, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the presentation of clinical data demonstrating the precision of MRI-guided delivery of the...

keyboard_arrow_left Page précédente